338 related articles for article (PubMed ID: 25914788)
1. Helicobacter pylori vs coronary heart disease - searching for connections.
Chmiela M; Gajewski A; Rudnicka K
World J Cardiol; 2015 Apr; 7(4):187-203. PubMed ID: 25914788
[TBL] [Abstract][Full Text] [Related]
2. Helicobacter pylori. One bacterium and a broad spectrum of human disease! An overview.
Pakodi F; Abdel-Salam OM; Debreceni A; Mózsik G
J Physiol Paris; 2000; 94(2):139-52. PubMed ID: 10791696
[TBL] [Abstract][Full Text] [Related]
3. Current treatment of Helicobacter pylori infection and peptic ulcer disease.
Cleghorn G
Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1997; 38(3):178-82. PubMed ID: 9230534
[TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori and urinary system stones: endoluminal damage as sub-hypothesis to support the current stone theory.
Verit A; Güner ND
Med Hypotheses; 2014 Dec; 83(6):677-80. PubMed ID: 25459132
[TBL] [Abstract][Full Text] [Related]
5.
Alexander SM; Retnakumar RJ; Chouhan D; Devi TNB; Dharmaseelan S; Devadas K; Thapa N; Tamang JP; Lamtha SC; Chattopadhyay S
Front Microbiol; 2021; 12():713955. PubMed ID: 34484153
[TBL] [Abstract][Full Text] [Related]
6. Infection with Helicobacter pylori is not a major independent risk factor for stable coronary heart disease: lack of a role of cytotoxin-associated protein A-positive strains and absence of a systemic inflammatory response.
Koenig W; Rothenbacher D; Hoffmeister A; Miller M; Bode G; Adler G; Hombach V; März W; Pepys MB; Brenner H
Circulation; 1999 Dec; 100(23):2326-31. PubMed ID: 10587336
[TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori: epidemiology and routes of transmission.
Brown LM
Epidemiol Rev; 2000; 22(2):283-97. PubMed ID: 11218379
[TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori-induced premature senescence of extragastric cells may contribute to chronic skin diseases.
Lewinska A; Wnuk M
Biogerontology; 2017 Apr; 18(2):293-299. PubMed ID: 28074309
[TBL] [Abstract][Full Text] [Related]
9. Helicobacter pylori: review of research findings.
Dooley CP
Aliment Pharmacol Ther; 1991; 5 Suppl 1():129-43. PubMed ID: 1888832
[TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
Kowalski M
J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
[TBL] [Abstract][Full Text] [Related]
11. Role of Helicobacter pylori infection in extragastroduodenal disorders: introductory remarks.
Konturek SJ; Konturek PC; Pieniazek P; Bielański W
J Physiol Pharmacol; 1999 Dec; 50(5):683-94. PubMed ID: 10695551
[TBL] [Abstract][Full Text] [Related]
12.
He J; Liu Y; Ouyang Q; Li R; Li J; Chen W; Hu W; He L; Bao Q; Li P; Hu C
Front Microbiol; 2022; 13():972777. PubMed ID: 35992650
[TBL] [Abstract][Full Text] [Related]
13. Biological evidence of the relationship between Helicobacter pylori and associated extragastric diseases.
Zendehdel A; Roham M
J Cell Biochem; 2019 Aug; 120(8):12128-12140. PubMed ID: 30977160
[TBL] [Abstract][Full Text] [Related]
14. Discovery by Jaworski of Helicobacter pylori and its pathogenetic role in peptic ulcer, gastritis and gastric cancer.
Konturek JW
J Physiol Pharmacol; 2003 Dec; 54 Suppl 3():23-41. PubMed ID: 15075463
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori antigens, acetylsalicylic acid, LDL and 7-ketocholesterol - their potential role in destabilizing the gastric epithelial cell barrier. An in vitro model of Kato III cells.
Gajewski A; Mnich E; Szymański K; Hinc K; Obuchowski M; Moran AP; Chmiela M
Acta Biochim Pol; 2016; 63(1):145-152. PubMed ID: 26619253
[TBL] [Abstract][Full Text] [Related]
16. How host regulation of Helicobacter pylori-induced gastritis protects against peptic ulcer disease and gastric cancer.
Dhar P; Ng GZ; Sutton P
Am J Physiol Gastrointest Liver Physiol; 2016 Sep; 311(3):G514-20. PubMed ID: 27469367
[TBL] [Abstract][Full Text] [Related]
17. [Helicobacter pylori--friend or foe?].
Ciortescu I; Stan M
Rev Med Chir Soc Med Nat Iasi; 2010; 114(3):619-24. PubMed ID: 21243784
[TBL] [Abstract][Full Text] [Related]
18. The prevalence of peptic ulcer not related to Helicobacter pylori or non-steroidal anti-inflammatory drug use is negligible in southern Europe.
Arroyo MT; Forne M; de Argila CM; Feu F; Arenas J; de la Vega J; Garrigues V; Mora F; Castro M; Bujanda L; Cosme A; Castiella A; Gisbert JP; Hervas A; Lanas A
Helicobacter; 2004 Jun; 9(3):249-54. PubMed ID: 15165261
[TBL] [Abstract][Full Text] [Related]
19. Extragastric manifestations of Helicobacter pylori infection: Possible role of bacterium in liver and pancreas diseases.
Rabelo-Gonçalves EM; Roesler BM; Zeitune JM
World J Hepatol; 2015 Dec; 7(30):2968-79. PubMed ID: 26730276
[TBL] [Abstract][Full Text] [Related]
20. Association of the presence of Helicobacter pylori in the oral cavity and in the stomach.
Cześnikiewicz-Guzik M; Karczewska E; Bielański W; Guzik TJ; Kapera P; Targosz A; Konturek SJ; Loster B
J Physiol Pharmacol; 2004 Jul; 55 Suppl 2():105-15. PubMed ID: 15608365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
